Patrizio Caturegli Selected Research

Autoimmune Hypophysitis

1/2021	Th17 Cells Contribute to the Pathology of Autoimmune Hypophysitis.
8/2017	Diabetes insipidus is an unfavorable prognostic factor for response to glucocorticoids in patients with autoimmune hypophysitis.
6/2017	Anti-pituitary antibodies against corticotrophs in IgG4-related hypophysitis.
8/2015	Autoimmune lymphocytic hypophysitis in association with autoimmune eye disease and sequential treatment with infliximab and rituximab.
7/2015	Rabphilin-3A as a Targeted Autoantigen in Lymphocytic Infundibulo-neurohypophysitis.
3/2013	Use of a clinicoradiological score to determine the presurgical diagnosis of autoimmune hypophysitis in a teenage girl.
5/2012	Placenta suppresses experimental autoimmune hypophysitis through soluble TNF receptor 1.
4/2012	Autoimmune hypophysitis: autoantigens and association with CTLA-4 blockade.
12/2011	Pituitary and systemic autoimmunity in a case of intrasellar germinoma.
12/2010	Preparation of mouse pituitary immunogen for the induction of experimental autoimmune hypophysitis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Patrizio Caturegli Research Topics

Disease

15	Thyroiditis 12/2021 - 02/2003
15	Hypophysitis 01/2021 - 07/2006
15	Autoimmune Hypophysitis 01/2021 - 06/2007
12	Autoimmune Thyroiditis (Lymphomatous Thyroiditis) 01/2020 - 12/2002
9	Hypothyroidism 09/2021 - 04/2005
8	Neoplasms (Cancer) 11/2019 - 12/2010
7	COVID-19 03/2022 - 10/2020
5	Autoimmune Diseases (Autoimmune Disease) 01/2020 - 12/2004
5	Hashimoto Disease (Thyroiditis, Hashimoto) 01/2015 - 01/2009
4	Infections 01/2022 - 10/2020
4	Inflammation (Inflammations) 12/2016 - 11/2004
3	Adenoma (Adenomas) 01/2021 - 07/2008
3	Thyroid Diseases (Thyroid Disease) 09/2011 - 02/2009
3	Graves Disease (Basedow Disease) 09/2011 - 10/2007
2	Cough 02/2022 - 01/2022
2	Pharyngitis (Sore Throat) 02/2022 - 01/2022
2	Hyperthyroidism 09/2021 - 06/2005
2	Melanoma (Melanoma, Malignant) 11/2019 - 04/2014
2	Adrenal Insufficiency (Adrenal Gland Hypofunction) 01/2017 - 07/2008
2	Paraproteinemias (Monoclonal Gammopathy) 05/2013 - 01/2011
2	Myocarditis (Carditis) 03/2012 - 11/2004
1	Thyroid Neoplasms (Thyroid Cancer) 10/2022
1	Crohn Disease (Crohn's Disease) 01/2022
1	Dermatomyositis (Dermatopolymyositis) 01/2022
1	Thyrotoxicosis 09/2021
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 10/2020
1	Congenital Hypothyroidism (Cretinism) 01/2020
1	Multiple Sclerosis 01/2020
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2020
1	Birth Weight (Birth Weights) 01/2020
1	Corneal Opacity 09/2019
1	Cataract (Cataracts) 09/2019
1	Fuchs' Endothelial Dystrophy 09/2019
1	Diabetes Insipidus 08/2017
1	Turner Syndrome (Turner's Syndrome) 01/2017
1	Eye Diseases (Eye Disease) 08/2015
1	Neurosarcoidosis 08/2015
1	Optic Neuritis (Retrobulbar Neuritis) 08/2015

Drug/Important Bio-Agent (IBA)

23	AntibodiesIBA 02/2022 - 07/2008
11	Thyroglobulin FDA Link 01/2016 - 04/2005
10	Proteins (Proteins, Gene)FDA Link 11/2020 - 12/2004
8	IodineIBA 10/2021 - 12/2002
7	Immunoglobulin G (IgG)IBA 03/2022 - 01/2011
7	CytokinesIBA 12/2021 - 02/2003
7	AutoantigensIBA 04/2012 - 06/2007
5	Immune Checkpoint InhibitorsIBA 12/2021 - 10/2019
5	AutoantibodiesIBA 01/2017 - 08/2008
4	Monoclonal AntibodiesIBA 11/2019 - 08/2011
4	IpilimumabIBA 11/2019 - 04/2014
4	GlucocorticoidsIBA 08/2017 - 07/2006
4	Interferon-gamma (Interferon, gamma)IBA 01/2016 - 11/2004
3	VaccinesIBA 03/2022 - 12/2021
3	Messenger RNA (mRNA)IBA 12/2021 - 08/2005
3	Thyrotropin Receptors (Thyrotropin Receptor)IBA 09/2021 - 02/2009
3	ChemokinesIBA 01/2021 - 12/2004
3	AlkaloidsIBA 01/2020 - 09/2012
3	CTLA-4 AntigenIBA 12/2016 - 11/2009
3	InterferonsIBA 08/2012 - 11/2004
3	Interleukin-12 (IL 12)IBA 10/2006 - 02/2003
2	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2021
2	EpitopesIBA 11/2020 - 01/2015
2	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2020 - 04/2014
2	isomyosmineIBA 01/2020 - 01/2019
2	Adrenocorticotropic Hormone (ACTH)FDA Link 04/2014 - 01/2010
2	ProlactinIBA 10/2013 - 01/2010
2	Hormones (Hormone)IBA 03/2013 - 03/2010
2	Growth Hormone (Somatotropin)IBA 12/2012 - 12/2011
2	AntigensIBA 12/2011 - 01/2007
2	sodium-iodide symporter (sodium iodide symporter)IBA 02/2009 - 08/2005
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 06/2005 - 12/2002
1	Iodide Peroxidase (Deiodinase)IBA 10/2022
1	FlagellinIBA 01/2022
1	Peptides (Polypeptides)IBA 01/2022
1	COVID-19 VaccinesIBA 12/2021
1	Biomarkers (Surrogate Marker)IBA 12/2021
1	Interleukin-6 (Interleukin 6)IBA 12/2021
1	Tamoxifen FDA LinkGeneric 10/2021
1	Apoptosis Regulatory ProteinsIBA 09/2021
1	ParaffinIBA 01/2021
1	Interleukin-17 (Interleukin 17)IBA 01/2021
1	Trans-Activators (Trans-Acting Factor)IBA 01/2021
1	Formaldehyde (Formol)FDA Link 01/2021
1	NucleoproteinsIBA 11/2020
1	Neutralizing AntibodiesIBA 11/2020
1	ProteomeIBA 11/2020
1	Nucleic AcidsIBA 10/2020
1	Dopamine (Intropin)FDA LinkGeneric 01/2020
1	Myelin-Oligodendrocyte GlycoproteinIBA 01/2020
1	NivolumabIBA 10/2019
1	atezolizumabIBA 10/2019
1	pembrolizumabIBA 10/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2016
1	Blocking AntibodiesIBA 12/2016
1	Drinking WaterIBA 01/2016
1	Rituximab (Mabthera)FDA Link 08/2015
1	Infliximab (Remicade)FDA Link 08/2015
1	Methotrexate (Mexate)FDA LinkGeneric 08/2015

Therapy/Procedure

7	Immunotherapy 09/2021 - 09/2008
5	Therapeutics 01/2020 - 06/2005
1	Slit Lamp 09/2019